# GB SCIENCES INC

GB SCIENCES INC is a company headquartered in Las Vegas, NV, United States.

## Company overview

- **Legal name:** GB SCIENCES INC
- **Former names in filing history:** Growblox Sciences, Inc. (2014-06-04 to 2017-05-12); Signature Exploration & Production Corp. (2008-06-02 to 2014-05-09); Diabetic Treatment Centers of America, Inc. (2004-08-16 to 2008-03-06); FLAGSTICK VENTURES INC (2002-02-12 to 2004-08-05)
- **Classification:** Company
- **Industry (SIC):** 1311 — Crude Petroleum & Natural Gas
- **Headquarters:** Las Vegas, NV, United States
- **Incorporated in:** NV
- **Fiscal year end:** March 31
- **SEC CIK:** 0001165320

## About

GB SCIENCES INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001165320, and its reported industry is Crude Petroleum & Natural Gas. In 10-K filed on 2024-08-30, it reported annual revenue of USD 0; net income of USD -1,361,677; total assets of USD 103,442 for the fiscal period ended 2024-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-03-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.4M (USD -1,361,677)
- **Total assets:** $103,442 (USD 103,442)
- **Cash and equivalents:** $11,991 (USD 11,991)
- **Operating cash flow:** -$975,698 (USD -975,698)

### FY2023 (period ended 2023-03-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$4.1M (USD -4,125,194)
- **Total assets:** $352,323 (USD 352,323)
- **Cash and equivalents:** $109,912 (USD 109,912)
- **Operating cash flow:** -$1.5M (USD -1,526,861)

### FY2022 (period ended 2022-03-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$530,873 (USD -530,873)
- **Total assets:** $2.5M (USD 2,549,900)
- **Cash and equivalents:** $233,893 (USD 233,893)
- **Operating cash flow:** -$1.9M (USD -1,866,154)

### FY2021 (period ended 2021-03-31)

- **Net income:** -$3.7M (USD -3,725,027)
- **Total assets:** $10.8M (USD 10,806,054)
- **Cash and equivalents:** $793,040 (USD 793,040)
- **Operating cash flow:** -$2.2M (USD -2,185,220)

## Recent SEC filings

- Form 10-Q — filed 2025-08-12 — period 2024-12-31 — FORM 10-Q
- Form 10-Q — filed 2024-11-27 — period 2024-09-30 — FORM 10-Q
- Form 10-Q — filed 2024-11-27 — period 2024-06-30 — FORM 10-Q
- Form 8-K — filed 2024-10-15 — period 2024-09-26 — FORM 8-K
- Form 10-K — filed 2024-08-30 — period 2024-03-31 — FORM 10-K
- Form 8-K — filed 2024-07-16 — period 2024-07-10 — FORM 8-K
- Form 8-K — filed 2024-06-21 — period 2024-06-18 — FORM 8-K
- Form 10-Q — filed 2024-02-12 — period 2023-12-31 — FORM 10-Q
- Form 10-Q — filed 2023-11-20 — period 2023-09-30 — FORM 10-Q
- Form 8-K — filed 2023-09-08 — period 2023-09-01 — GB SCIENCES, INC. - FORM 8-K SEC FILING
- Form 10-Q — filed 2023-08-14 — period 2023-06-30 — FORM 10-Q
- Form 10-K — filed 2023-07-14 — period 2023-03-31 — FORM 10-K

---

Updated: 2026-10-23T20:10:52Z

Canonical page: https://altss.com/profile/gb-sciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology